SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-005849
Filing Date
2018-05-10
Accepted
2018-05-10 16:32:49
Documents
39
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0318_actinium.htm 10-Q 196624
2 CERTIFICATION f10q0318ex31i_actiniumpharm.htm EX-31.1 12011
3 CERTIFICATION f10q0318ex31ii_actiniumpharm.htm EX-31.2 13148
4 CERTIFICATION f10q0318ex32i_actiniumpharm.htm EX-32.1 4842
5 CERTIFICATION f10q0318ex32ii_actiniumpharm.htm EX-32.2 6092
  Complete submission text file 0001213900-18-005849.txt   1661440

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE atnm-20180331.xml EX-101.INS 186925
7 XBRL SCHEMA FILE atnm-20180331.xsd EX-101.SCH 27348
8 XBRL CALCULATION FILE atnm-20180331_cal.xml EX-101.CAL 28003
9 XBRL DEFINITION FILE atnm-20180331_def.xml EX-101.DEF 103707
10 XBRL LABEL FILE atnm-20180331_lab.xml EX-101.LAB 217185
11 XBRL PRESENTATION FILE atnm-20180331_pre.xml EX-101.PRE 155940
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 18823071
SIC: 2834 Pharmaceutical Preparations